Attwell Luke, Vassallo Michael
Royal Bournemouth & Christchurch Hospitals NHS Foundation Trust, Castle Lane East, Bournemouth BH7 7DW, UK.
Bournemouth University, Poole BH12 5BB, UK.
Geriatrics (Basel). 2017 Jan 22;2(1):9. doi: 10.3390/geriatrics2010009.
Frailty and sarcopenia are two important clinical syndromes associated with the ageing process, with a high risk of morbidity and mortality. Patients with chronic disease have been shown to have an accelerated decline into a frail state, with patients with both chronic lung disease and frailty having a higher mortality than those with frailty alone. Pulmonary rehabilitation has been found to be an effective intervention in patients with chronic obstructive pulmonary disease (COPD), yet the effect of frailty on this as intervention remains unclear. A narrative literature search of PubMed, Medline complete and the Cochrane library was performed by the reviewers using predefined criteria. Only 3 studies met the selection criteria and were reviewed. These studies highlighted that, although completion rates are lower in patients with both COPD and frailty, pulmonary rehabilitation remains effective as an intervention in this subgroup of patients, with up to 61% of frail patients no longer meeting frailty criteria after completion of a pulmonary rehabilitation programme.
衰弱和肌少症是与衰老过程相关的两种重要临床综合征,具有较高的发病和死亡风险。已证实患有慢性病的患者会加速进入衰弱状态,患有慢性肺病和衰弱的患者比仅患有衰弱的患者死亡率更高。肺康复已被发现是慢性阻塞性肺疾病(COPD)患者的一种有效干预措施,但衰弱对这种干预措施的影响仍不清楚。 reviewers使用预定义标准对PubMed、Medline complete和Cochrane图书馆进行了叙述性文献检索。只有3项研究符合入选标准并进行了综述。这些研究强调,尽管COPD和衰弱患者的完成率较低,但肺康复作为该亚组患者的一种干预措施仍然有效,在完成肺康复计划后,高达61%的衰弱患者不再符合衰弱标准。